SESN2 and diabetic kidney disease: The aim of this work was to evaluate three autophagy regulators; Rubicon (RUBCN), mTOR and Sestrin-2 (SESN2) as clinically applicable biomarkers of diabetic nephropathy; and to assess if they can be used to predict the development of nephropathy in diabetic patients.